With the advances in the management of head and neck cancer (HNC), patients tend to survive longer after their diagnosis. These people face the burden of chronic pain management which is strongly associated with HNC. A HNC team in Portland...
Over the centuries, military conflicts and wars have caused both death and injuries and led to improvements in the care of the combat wounded. Military otolaryngologist-head and neck surgeons have been at the forefront of these developments and advances. War...
Ida Institute Founder Lise Lotte Bundesen will retire as Managing Director in July, 2022. During Bundesen’s 15-year tenure, the nonprofit institute’s impact and influence has grown exponentially.
Preventing an avoidable hearing loss before it begins would be the public health dream. In this article Kathleen Campbell takes us through one option that is showing the potential to fulfil that ambition. Kathleen explains the development of a preventative...
Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.
Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...
Report By: Professor John Fenton The annual Head and Neck Section of the 26th Sylvester O Halloran Surgical Scientific meeting was held at the University of Limerick Medical School (UL-GEMS) on 2 March 2019. Unfortunately the 2018 conference had to...
We few, we happy few, we band of brothers; For he to-day that sheds his blood with me Shall be my brother; be he ne’er so vile, This day shall gentle his condition: And gentlemen in England now a-bed Shall...
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.
Professor Patrick Axon, President of the UK’s Royal Society of Medicine Otology Section and Michelle Wyatt, incoming President of the section of Laryngology and Rhinology, look forward to the year ahead.
In this Belgian study, the authors looked at the impact of delaying otologic surgery by sending an online survey to 44 adult patients diagnosed with benign ear pathology whose surgery was postponed due to the COVID-19 pandemic. The questionnaire was...
“Dr Marion P Downs, an innovator in the field of paediatric audiology and a tireless advocate for the early identification of hearing loss, passed away on November 13, 2014. During her exemplary career at the University of Colorado Health Sciences...